Tower Research Capital LLC (Trc) Glaukos Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Glaukos Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 5,804 shares of GKOS stock, worth $490,379. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,804
Previous 1,242
367.31%
Holding current value
$490,379
Previous $122,000
390.98%
% of portfolio
0.02%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding GKOS
# of Institutions
334Shares Held
54MCall Options Held
259KPut Options Held
481K-
Black Rock Inc. New York, NY8.04MShares$679 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$516 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.24MShares$274 Million0.06% of portfolio
-
State Street Corp Boston, MA2.09MShares$177 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN2MShares$169 Million0.05% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.02B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...